These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10047972)

  • 41. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
    Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
    Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus antibody and risk of prostate cancer.
    Hisada M; Rabkin CS; Strickler HD; Wright WE; Christianson RE; van den Berg BJ
    JAMA; 2000 Jan; 283(3):340-1. PubMed ID: 10647795
    [No Abstract]   [Full Text] [Related]  

  • 45. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HPV persistence and its oncogenic role in prostate tumors.
    Tachezy R; Hrbacek J; Heracek J; Salakova M; Smahelova J; Ludvikova V; Svec A; Urban M; Hamsikova E
    J Med Virol; 2012 Oct; 84(10):1636-45. PubMed ID: 22930513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate Cancer in Southern Africa: Does Africa Hold Untapped Potential to Add Value to the Current Understanding of a Common Disease?
    Hayes VM; Bornman MSR
    J Glob Oncol; 2018 Sep; 4():1-7. PubMed ID: 30241160
    [No Abstract]   [Full Text] [Related]  

  • 48. Genetics: prostate cancer.
    Blaine SM; Honeywell C; Allanson J; Cremin C; Dorman H; Gibbons CA; Meschino WS; Permaul J; Carroll JC
    Can Fam Physician; 2009 Jul; 55(7):710. PubMed ID: 19602656
    [No Abstract]   [Full Text] [Related]  

  • 49. Prostate cancer: the interplay between genetics and the environment.
    Albertsen P
    BJU Int; 2021 Jun; 127(6):615-616. PubMed ID: 34096163
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy.
    Kamiya S; Nakamori Y; Takasawa A; Takasawa K; Kyuno D; Ono Y; Magara K; Osanai M
    Med Mol Morphol; 2023 Jun; 56(2):85-93. PubMed ID: 36749415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raman Spectroscopy: A Personalized Decision-Making Tool on Clinicians' Hands for In Situ Cancer Diagnosis and Surgery Guidance.
    Kouri MA; Spyratou E; Karnachoriti M; Kalatzis D; Danias N; Arkadopoulos N; Seimenis I; Raptis YS; Kontos AG; Efstathopoulos EP
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steroid 5 alpha-reductase 2 enzyme variants, biomass exposure and tobacco use in Mexican patients with prostate cancer.
    Delgado-Balderas JR; Gallardo-Blanco HL; Yee-De León JF; Rivas-Estilla AM; Soto-García B; Aráiz-Hernández D; Garza-Guajardo R; Náñez-Marín M; Hernández-Barajas D; García-Bailón AM; Vízcarra-Mata G; Ocaña-Munguía MA; Gómez-Guerra LS; Sánchez-Domínguez CN
    Oncol Lett; 2020 Nov; 20(5):261. PubMed ID: 32989395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition on JNK Mimics Silencing of Wnt-11 Mediated Cellular Response in Androgen-Independent Prostate Cancer Cells.
    Arisan ED; Rencuzogullari O; Keskin B; Grant GH; Uysal-Onganer P
    Biology (Basel); 2020 Jun; 9(7):. PubMed ID: 32605008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial.
    Basir A
    Asian Pac J Cancer Prev; 2019 May; 20(5):1445-1451. PubMed ID: 31127906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!
    Costello LC; Franklin RB
    Oncol Rev; 2018 Jul; 12(2):356. PubMed ID: 30093983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.
    Maximov PY; Abderrahman B; Curpan RF; Hawsawi YM; Fan P; Jordan VC
    Endocr Relat Cancer; 2018 Feb; 25(2):R83-R113. PubMed ID: 29162647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
    Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD
    BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
    Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; ; ; ; ; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
    PLoS Genet; 2014 Feb; 10(2):e1004129. PubMed ID: 24550738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate-specific antigen: any successor in sight?
    Obort AS; Ajadi MB; Akinloye O
    Rev Urol; 2013; 15(3):97-107. PubMed ID: 24223021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.